Automated Insulin Delivery System Market by Disease Type (Type I Diabetes, Type II Diabetes), Distribution (Diabetes Clinics, Hospital Pharmacies, Retail Pharmacies) - Global Forecast 2024-2030
The Automated Insulin Delivery System Market size was estimated at USD 821.39 million in 2023 and expected to reach USD 901.04 million in 2024, at a CAGR 9.79% to reach USD 1,579.49 million by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Automated Insulin Delivery System Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Automated Insulin Delivery System Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Automated Insulin Delivery System Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Animas Corporation, Becton, Dickinson and Company, Bigfoot Biomedical Inc., Biocon Limited, Dexcom, Inc., Diabeloop S.A., DreaMed Diabetes Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Insulet Corporation, Medtronic PLC, Novo Nordisk A/S, Sanofi S.A., and Tandem Diabetes Care, Inc..
Market Segmentation & Coverage
This research report categorizes the Automated Insulin Delivery System Market to forecast the revenues and analyze trends in each of the following sub-markets:
Disease Type
Type I Diabetes
Diabetes Clinics
Americas
Argentina
California
Australia
Denmark
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast of the Automated Insulin Delivery System Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Automated Insulin Delivery System Market?
- What are the technology trends and regulatory frameworks in the Automated Insulin Delivery System Market?
- What is the market share of the leading vendors in the Automated Insulin Delivery System Market?
- Which modes and strategic moves are suitable for entering the Automated Insulin Delivery System Market?
Note: PDF & Excel + Online Access - 1 Year
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Automated Insulin Delivery System Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising prevalence of diabetes coupled with increasing number of awareness campaigns
- 5.1.1.2. Availability of improved pipelined and marketed AID systems
- 5.1.1.3. Developments in AID systems with improved clinical outcomes
- 5.1.2. Restraints
- 5.1.2.1. Calibration of a glucose sensor, sensor durability, skin-related issues
- 5.1.3. Opportunities
- 5.1.3.1. Up-gradation of existing insulin pumps and new product developmen
- 5.1.3.2. Increasing R&D activities for the production of innovative insulin delivery systems
- 5.1.4. Challenges
- 5.1.4.1. Concerns regarding pump imprecision and sensor inaccuracy or unreliability
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Automated Insulin Delivery System Market, by Disease Type
- 6.1. Introduction
- 6.2. Type I Diabetes
- 6.3. Type II Diabetes
- 7. Automated Insulin Delivery System Market, by Distribution
- 7.1. Introduction
- 7.2. Diabetes Clinics
- 7.3. Hospital Pharmacies
- 7.4. Retail Pharmacies
- 8. Americas Automated Insulin Delivery System Market
- 8.1. Introduction
- 8.2. Argentina
- 8.3. Brazil
- 8.4. Canada
- 8.5. Mexico
- 8.6. United States
- 9. Asia-Pacific Automated Insulin Delivery System Market
- 9.1. Introduction
- 9.2. Australia
- 9.3. China
- 9.4. India
- 9.5. Indonesia
- 9.6. Japan
- 9.7. Malaysia
- 9.8. Philippines
- 9.9. Singapore
- 9.10. South Korea
- 9.11. Taiwan
- 9.12. Thailand
- 9.13. Vietnam
- 10. Europe, Middle East & Africa Automated Insulin Delivery System Market
- 10.1. Introduction
- 10.2. Denmark
- 10.3. Egypt
- 10.4. Finland
- 10.5. France
- 10.6. Germany
- 10.7. Israel
- 10.8. Italy
- 10.9. Netherlands
- 10.10. Nigeria
- 10.11. Norway
- 10.12. Poland
- 10.13. Qatar
- 10.14. Russia
- 10.15. Saudi Arabia
- 10.16. South Africa
- 10.17. Spain
- 10.18. Sweden
- 10.19. Switzerland
- 10.20. Turkey
- 10.21. United Arab Emirates
- 10.22. United Kingdom
- 11. Competitive Landscape
- 11.1. FPNV Positioning Matrix
- 11.2. Market Share Analysis, By Key Player
- 11.3. Competitive Scenario Analysis, By Key Player
- 12. Competitive Portfolio
- 12.1. Key Company Profiles
- 12.1.1. Abbott Laboratories
- 12.1.2. Animas Corporation
- 12.1.3. Becton, Dickinson and Company
- 12.1.4. Bigfoot Biomedical Inc.
- 12.1.5. Biocon Limited
- 12.1.6. Dexcom, Inc.
- 12.1.7. Diabeloop S.A.
- 12.1.8. DreaMed Diabetes Ltd.
- 12.1.9. Eli Lilly and Company
- 12.1.10. F. Hoffmann-La Roche Ltd.
- 12.1.11. Insulet Corporation
- 12.1.12. Medtronic PLC
- 12.1.13. Novo Nordisk A/S
- 12.1.14. Sanofi S.A.
- 12.1.15. Tandem Diabetes Care, Inc.
- 12.2. Key Product Portfolio
- 13. Appendix
- 13.1. Discussion Guide
- 13.2. License & Pricing
- FIGURE 1. AUTOMATED INSULIN DELIVERY SYSTEM MARKET RESEARCH PROCESS
- FIGURE 2. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, 2023 VS 2030
- FIGURE 3. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. AUTOMATED INSULIN DELIVERY SYSTEM MARKET DYNAMICS
- FIGURE 7. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
- FIGURE 8. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
- FIGURE 10. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 12. AMERICAS AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. UNITED STATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 14. UNITED STATES AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. AUTOMATED INSULIN DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 20. AUTOMATED INSULIN DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook